Clayton Sean M. 4
4 · Horizon Therapeutics Public Ltd Co · Filed Mar 6, 2023
Insider Transaction Report
Form 4
Clayton Sean M.
EVP, General Counsel
Transactions
- Exercise/Conversion
Ordinary Shares
2023-03-01+14,129→ 14,408 total - Exercise/Conversion
Restricted Stock Units
2023-03-01+14,129→ 28,258 total→ Ordinary shares (14,129 underlying) - Tax Payment
Ordinary Shares
2023-03-01$110.34/sh−7,032$775,911→ 7,376 total
Holdings
- 745(indirect: See footnote)
Ordinary Shares
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F2]Includes 279 ordinary shares of the Issuer acquired by the reporting person on December 1, 2022 pursuant to an employee stock purchase program.
- [F3]The shares are held by the Clayton Family Trust, of which the Reporting Person is the co-trustee and beneficiary.
- [F4]The shares subject to the restricted stock units vest 1/3rd annually on each anniversary of March 1, 2022.